Annual EBITDA
-$58.79 M
+$93.82 M+61.48%
December 31, 2023
Summary
- As of February 7, 2025, WVE annual EBITDA is -$58.79 million, with the most recent change of +$93.82 million (+61.48%) on December 31, 2023.
- During the last 3 years, WVE annual EBITDA has risen by +$84.60 million (+59.00%).
- WVE annual EBITDA is now -1682.60% below its all-time high of -$3.30 million, reached on December 31, 2013.
Performance
WVE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$61.76 M
-$28.93 M-88.14%
September 30, 2024
Summary
- As of February 7, 2025, WVE quarterly EBITDA is -$61.76 million, with the most recent change of -$28.93 million (-88.14%) on September 30, 2024.
- Over the past year, WVE quarterly EBITDA has dropped by -$45.26 million (-274.28%).
- WVE quarterly EBITDA is now -1020.65% below its all-time high of $6.71 million, reached on September 30, 2023.
Performance
WVE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$143.36 M
-$68.47 M-91.41%
September 30, 2024
Summary
- As of February 7, 2025, WVE TTM EBITDA is -$143.36 million, with the most recent change of -$68.47 million (-91.41%) on September 30, 2024.
- Over the past year, WVE TTM EBITDA has dropped by -$84.57 million (-143.86%).
- WVE TTM EBITDA is now -11250.99% below its all-time high of -$1.26 million, reached on September 30, 2014.
Performance
WVE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
WVE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.5% | -274.3% | -143.9% |
| 3 y3 years | +59.0% | -274.3% | -143.9% |
| 5 y5 years | +61.8% | -274.3% | -143.9% |
WVE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.5% | -1020.6% | at low | -143.9% | +6.1% |
| 5 y | 5-year | at high | +70.5% | -1020.6% | at low | -143.9% | +28.6% |
| alltime | all time | -1682.6% | +70.5% | -1020.6% | at low | <-9999.0% | +28.6% |
Wave Life Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$61.76 M(+88.1%) | -$143.36 M(+91.4%) |
| Jun 2024 | - | -$32.83 M(+1.7%) | -$74.90 M(+18.5%) |
| Mar 2024 | - | -$32.28 M(+95.6%) | -$63.22 M(+7.5%) |
| Dec 2023 | -$58.79 M(-61.5%) | -$16.50 M(-346.0%) | -$58.79 M(-29.5%) |
| Sep 2023 | - | $6.71 M(-131.7%) | -$83.36 M(-34.0%) |
| Jun 2023 | - | -$21.15 M(-24.0%) | -$126.36 M(-12.8%) |
| Mar 2023 | - | -$27.85 M(-32.2%) | -$144.87 M(-5.1%) |
| Dec 2022 | -$152.61 M(+30.2%) | -$41.07 M(+13.1%) | -$152.61 M(+5.2%) |
| Sep 2022 | - | -$36.30 M(-8.5%) | -$145.11 M(+27.3%) |
| Jun 2022 | - | -$39.66 M(+11.5%) | -$114.02 M(+2.0%) |
| Mar 2022 | - | -$35.58 M(+6.0%) | -$111.75 M(-4.6%) |
| Dec 2021 | -$117.18 M(-18.3%) | -$33.57 M(+544.4%) | -$117.18 M(+5.2%) |
| Sep 2021 | - | -$5.21 M(-86.1%) | -$111.41 M(-19.3%) |
| Jun 2021 | - | -$37.39 M(-8.8%) | -$138.11 M(+0.9%) |
| Mar 2021 | - | -$41.01 M(+47.5%) | -$136.89 M(-4.5%) |
| Dec 2020 | -$143.39 M(-28.0%) | -$27.80 M(-12.9%) | -$143.39 M(-17.4%) |
| Sep 2020 | - | -$31.91 M(-11.8%) | -$173.69 M(-10.3%) |
| Jun 2020 | - | -$36.17 M(-23.9%) | -$193.61 M(-3.6%) |
| Mar 2020 | - | -$47.51 M(-18.2%) | -$200.80 M(+0.8%) |
| Dec 2019 | -$199.12 M | -$58.10 M(+12.1%) | -$199.12 M(+5.8%) |
| Sep 2019 | - | -$51.82 M(+19.5%) | -$188.24 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$43.37 M(-5.4%) | -$173.19 M(+4.9%) |
| Mar 2019 | - | -$45.82 M(-3.0%) | -$165.17 M(+7.3%) |
| Dec 2018 | -$153.94 M(+53.6%) | -$47.23 M(+28.4%) | -$153.94 M(+12.4%) |
| Sep 2018 | - | -$36.77 M(+4.1%) | -$136.98 M(+8.7%) |
| Jun 2018 | - | -$35.34 M(+2.1%) | -$125.97 M(+9.6%) |
| Mar 2018 | - | -$34.60 M(+14.3%) | -$114.94 M(+14.7%) |
| Dec 2017 | -$100.24 M(+82.5%) | -$30.27 M(+17.5%) | -$100.24 M(+13.1%) |
| Sep 2017 | - | -$25.76 M(+5.9%) | -$88.61 M(+10.9%) |
| Jun 2017 | - | -$24.32 M(+22.2%) | -$79.89 M(+19.2%) |
| Mar 2017 | - | -$19.89 M(+6.7%) | -$67.03 M(+22.0%) |
| Dec 2016 | -$54.94 M(+193.7%) | -$18.64 M(+9.3%) | -$54.94 M(+26.6%) |
| Sep 2016 | - | -$17.05 M(+48.8%) | -$43.38 M(+39.8%) |
| Jun 2016 | - | -$11.45 M(+46.9%) | -$31.04 M(+34.2%) |
| Mar 2016 | - | -$7.80 M(+10.1%) | -$23.13 M(+23.6%) |
| Dec 2015 | -$18.70 M(+265.8%) | -$7.08 M(+50.5%) | -$18.70 M(+40.5%) |
| Sep 2015 | - | -$4.71 M(+32.9%) | -$13.32 M(+34.9%) |
| Jun 2015 | - | -$3.54 M(+4.9%) | -$9.87 M(+55.9%) |
| Mar 2015 | - | -$3.38 M(+99.3%) | -$6.33 M(+114.2%) |
| Dec 2014 | -$5.11 M(+55.0%) | -$1.69 M(+34.1%) | -$2.96 M(+134.1%) |
| Sep 2014 | - | -$1.26 M | -$1.26 M |
| Dec 2013 | -$3.30 M | - | - |
FAQ
- What is Wave Life Sciences annual EBITDA?
- What is the all time high annual EBITDA for Wave Life Sciences?
- What is Wave Life Sciences annual EBITDA year-on-year change?
- What is Wave Life Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Wave Life Sciences?
- What is Wave Life Sciences quarterly EBITDA year-on-year change?
- What is Wave Life Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Wave Life Sciences?
- What is Wave Life Sciences TTM EBITDA year-on-year change?
What is Wave Life Sciences annual EBITDA?
The current annual EBITDA of WVE is -$58.79 M
What is the all time high annual EBITDA for Wave Life Sciences?
Wave Life Sciences all-time high annual EBITDA is -$3.30 M
What is Wave Life Sciences annual EBITDA year-on-year change?
Over the past year, WVE annual EBITDA has changed by +$93.82 M (+61.48%)
What is Wave Life Sciences quarterly EBITDA?
The current quarterly EBITDA of WVE is -$61.76 M
What is the all time high quarterly EBITDA for Wave Life Sciences?
Wave Life Sciences all-time high quarterly EBITDA is $6.71 M
What is Wave Life Sciences quarterly EBITDA year-on-year change?
Over the past year, WVE quarterly EBITDA has changed by -$45.26 M (-274.28%)
What is Wave Life Sciences TTM EBITDA?
The current TTM EBITDA of WVE is -$143.36 M
What is the all time high TTM EBITDA for Wave Life Sciences?
Wave Life Sciences all-time high TTM EBITDA is -$1.26 M
What is Wave Life Sciences TTM EBITDA year-on-year change?
Over the past year, WVE TTM EBITDA has changed by -$84.57 M (-143.86%)